image

image

Melanoma News

Study: Tanning beds definitely cause cancer

Updated: 7/29/2009 2:54:43 PM

LONDON -- International cancer experts have moved tanning beds and ultraviolet radiation into the top cancer risk category deeming both to be definite causes of cancer.

For years, scientists have described tanning beds and ultraviolet radiation as "probable carcinogens."

A new analysis of about 20 studies concludes the risk of skin cancer jumps by 75 percent when people start using tanning beds before age 30.

Experts also found that all types of ultraviolet radiation caused worrying mutations in mice, proof the radiation is carcinogenic. Previously, only one type of ultraviolet radiation was thought to be lethal.

The new classification means tanning beds and ultraviolet radiation are definite causes of cancer, alongside tobacco, the hepatitis B virus and chimney sweeping, among others.

The research was published online in the medical journal Lancet Oncology on Wednesday by experts at the International Agency for Research on Cancer in Lyon, the cancer arm of the World Health Organization.

"People need to be reminded of the risks of sunbeds," said Vincent Cogliano, one of the cancer researchers. "We hope the prevailing culture will change so teens don't think they need to use sunbeds to get a tan."

Cogliano said the classification means experts are confident that tanning beds cause cancer, but he noted they may not be as potent as other carcinogens like tobacco or arsenic.

Most lights used in tanning beds give off mainly ultraviolet radiation, which cause skin and eye cancer. As use of tanning beds has increased among people under 30, doctors have seen a parallel rise in the numbers of young people with skin cancer, though most types of skin cancer are benign.

According to the studies reviewed by Cogliano and colleagues, using tanning beds caused about a 20 percent increased relative risk of developing melanoma, the deadliest kind of skin cancer.

Cogliano said it was impossible to know how many benign skin cancers might be caused by tanning beds, because of complicating factors like exposure to regular sunlight. He and colleagues examined data from more than 7,000 melanoma cases and found a strong association between tanning bed use and the disease. He compared the link to that found between tobacco and lung cancer.

In Britain, melanoma is now the leading cancer diagnosed in women in their 20s. Normally, skin cancer rates are highest in people over 75. According to a British study from 2003, about 100 people every year die of melanoma attributable to tanning beds.

Previous studies found younger people who regularly use tanning beds are eight times more likely to get melanoma than people who have never used them. In the past, WHO warned people younger than 18 to stay away from tanning beds.

The American Cancer Society advises people to try bronzing or self-tanning creams instead of tanning beds. (Copyright 2009 by The Associated Press. All Rights Reserved.)

All Material Copyright 2009 KARE-11. All Rights Reserved.
pic

WebMD: Better Information. Better Health.
January 19, 2009 Skip to content

Melanoma Increase Is Real

Study Shows Rise in Melanoma Isn't Just Due to Better Screening
By Kathleen Doheny
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 8, 2009 -- The increase in the potentially deadly skin cancer melanoma that has occurred over the last several decades can't be linked just to better screening and earlier detection of the cancer, according to a new study.

For years, experts have debated whether the dramatic rise in melanoma -- one of the fastest growing cancers worldwide -- is a true increase or just a reflection of better and expanded screening, with doctors simply finding more cases and at earlier stages.

In the new study, researchers looked at people in lower socioeconomic classes who typically don't have ideal access to health care and also took into account factors such as the severity or thickness of the melanoma tumors at diagnosis.

Increases in melanomas occurred for tumors of all thicknesses, and the incidence doubled in all socioeconomic groups over a 10-year period studied.

The conclusion? "The rise in the melanoma rates is at least partly due to a real increase," says study researcher Eleni Linos, MD, DrPH, a dermatology resident at Stanford University in California. The study was published online in the Journal of Investigative Dermatology.

About 62,000 new cases of melanoma were diagnosed in the U.S. in 2008, according to the American Cancer Society, and about 8,000 people died of it in 2008. The tumors are usually brown or black and often appear on the face, neck, trunk, and legs.

Melanoma Thickness

Linos and her colleagues analyzed more than 70,000 new cases of malignant melanoma diagnosed from 1992 to 2004, drawing data from a national program known as the Surveillance Epidemiology and End Results (SEER). They also looked at a smaller subset of nearly 30,000 cases from California, where information on the patients' socioeconomic status was available.

They looked, too, at how thick the tumor was at diagnosis. "If you have a very thin tumor when diagnosed, you have a good prognosis," says Myles Cockburn, PhD, associate professor of preventive medicine at the University of Southern California Keck School of Medicine and a study researcher. A tumor that is thick at diagnosis -- greater than 4 millimeters -- has a much bleaker prognosis, he tells WebMD.

Overall, the incidence of melanoma increased by 3.1% per year, the research team found. The increases occurred for tumors of all thicknesses, including those over 4 millimeters.

The biggest increase, Linos says, was found in men over age 65. Both the incidence of melanoma and the death rates are going up in that group.

"Melanoma rates are going up, especially in men over 65 years of age, where they exceed 125 new cases per 100,000 people," she says. "Melanoma rates are going up across all socioeconomic groups and regardless of tumor thickness."

Linos stops short of calling it an epidemic, saying that it is a "true rise" in incidence.

Melanoma Study: Second Opinion

While the new findings probably won't lay to rest the debate in the scientific community about whether the rise in melanoma cases is a true epidemic, the findings do show a true rise in melanoma, agrees Steven Wang, MD, director of dermatologic surgery and dermatology at Memorial Sloan-Kettering Cancer Center and a member of The Skin Cancer Foundation's Photobiology Committee.

"There is no debate about the rising incidence of melanoma," he says. "We should turn this around and focus on the more important questions." Those include finding better treatments for advanced melanoma, he tells WebMD. Finding tumors earlier is a good thing, he adds. "It can avoid [the need for] aggressive surgery, for instance."

"They showed the thicker tumors, which are much less likely to be incorrectly diagnosed as melanoma, increased as well," says Martin A. Weinstock, MD, PhD, professor of dermatology and community health at Brown University and chairman of the American Cancer Society Skin Cancer Advisory Committee. "That is probably the single most important observation they made, because it does suggest that indeed the increase in incidence is real as opposed to an artifact of early detection activity.''

The emphasis, agrees Cockburn, should shift from the current debate. What's important is finding out why the incidence isn't declining and emphasizing the need to get screened. "Screening is really important," he says "You should ask your doctor for a skin exam."

The Skin Cancer Foundation recommends that everyone perform a self-exam once a month, consulting a dermatologist if they find worrisome symptoms, and get a skin exam from a dermatologist yearly.

Limiting sunlight exposure, wearing sunscreen, and wearing protective clothing including a hat are recommended by the American Cancer Society.

SOURCES:

Linos, E. Journal of Investigative Dermatology, online Jan. 8, 2009.

Myles Cockburn, PhD, associate professor of preventive medicine, University of Southern California Keck School of Medicine, Los Angeles.

Steven Wang, MD, director of dermatologic surgery and dermatology, Memorial Sloan-Kettering Cancer Center, Basking Ridge, N.J.; member, The Skin Cancer Foundation's Photobiology Committee.

American Cancer Society: "What Are the Key Statistics About Melanoma?"

Martin A. Weinstock, MD, PhD, chairman, American Cancer Society Skin Cancer Advisory Committee; professor of dermatology and community health, Brown University, Providence, R.I.

© 2009 WebMD, LLC. All rights reserved.

 

 

Skin Cancer Statistics: What You Need to Know

by  Kevin Berman, MD, PhD
Wednesday, September 17, 2008

Hi everyone. I want to talk about some simple statistics about skin cancer so you can see how it affects so many lives. This is especially important for younger people who seem to feel they are invincible and cannot imagine that their behavior (such as using a tanning bed) will affect their health and their lives years down the road. Although skin cancer may not be completely preventable, we can certainly decrease the number of cases for the future.

The first number is one million; this is the number of new skin cancers that will be diagnosed this year. That is a staggering number as cancers of the skin are the most commonly diagnosed cancers by a large margin. This means that millions of lives are affected as friends' and family members' lives are also changed as a result of the diagnosis. And with such a large number of cancers, the cost associated with diagnosis and treatment is between one and two billion dollars. There are also the costs of days of work missed, lost wages, and other hard to determine costs. This is a lot of money and drives up the cost of health insurance for individuals as well as tax dollars (for money that is spent by medicare and other government sponsored health plans). So even if you do not know anyone with skin cancer, you are paying for it to some extent.

The skin cancer that we fear most is melanoma, as it causes over 75% of all skin cancer deaths. A very scary number is that 1 in 63 people will develop invasive melanoma and the frequency continues to increase. While melanoma is the sixth most common cancer in men and women, it is the second most common cancer diagnosed in women between the ages of 20 and 30. This is very scary as it is increasingly becoming a cancer of young people and over 8000 people will die this year from melanoma. Most likely, increased sun exposure in young women is leading the increased rate of diagnosis in this group although other factors certainly are playing an important role. So for all the twenty-somethings who feel invincible, this is a reminder that life is a fragile state. On the upside, the five year survival rate for melanomas diagnosed very early is 99%, which is another reason to put a skin check on your yearly schedule. Furthermore, the more commonly diagnosed squamous cell and basal cell carcinomas have a greater than 95% cure rate when treated early. So while the burden of disease of skin cancer may be great, early detection and treatment can lead to cure and not reduce life expectancy.

While these statistics may appear scary or daunting, they simply reflect the amount of skin disease currently being diagnosed and treated. There are probably many more skin cancers that go untreated as many people do not seek medical care. Although the current trends suggest that we will see a further increase is skin cancers in the near and distant future, we can change this course as we learn more about prevention and alter our behavior. This is why sun protection is important since the sun is a known culprit for causing skin cancer. Prevention will always be the best treatment and we can be better at preventing skin cancer in the future.

Disease & Illness

Melanoma Could Be In Your Genes

By: Heather Hajek
Published: Friday, 26 September 2008

Individuals with a variation of a Vitamin D gene, known as BSMI, have a greater risk of suffering from melanoma, a form of skin cancer that can be deadly. Melanoma is the most serious form of skin cancer. The chances of being diagnosed with skin cancer increase as we age, but it is one of the most common forms of cancer in young adults. Annually over 50,000 Americans are diagnosed with melanoma. When melanoma is found in its early stages, recovery is usually very positive. When melanoma grows deeper into the skin and spreads to other organs it is very hard to cure.

Vitamin D deficiencies have been linked to both colon and breast cancer. Now, through a new study, based on data from six previous studies, including 2,152 melanoma patients and 2,410 patients without melanoma, researchers discovered patients with the BSMI variant had a 30 percent higher risk of melanoma, as reported in the online edition of Cancer. During the study, scientist examined the effects of five vitamin D receptors gene variants and their added risks on melanoma. The researchers concluded that the FokI variant had no effect on the risk of melanoma and they were unable to draw a clear conclusion on the other variants effects, with the exception of BSMI, which increased risks for patients.

Vitamin D in the body can be a defender of cancer, because of its key functions of regulating cell growth, cell differentiation and cell death. Vitamin D binds with receptors within a cell, where it exerts its effects. Individuals seem to have varying genetic differences with Vitamin D receptors, investigators have noted. Which directs them to believe people may have different levels of Vitamin D throughout their bodies, resulting in some patients naturally having more protection from cancer than others.

A few minutes in the nice warm air always seems refreshing, but we have all seen the warning in regards to the dangers of the suns rays. Sun exposure can have positive effects, by increasing levels of Vitamin D in the skin. However, sun exposure is always recommended with some form of sunscreen. Based on the recent study, the researchers have discovered more detailed research is needed to prove that indirect sun exposure may have anti-melanoma effects, and whether one specific vitamin D receptor is independently associated with a greater risk for melanoma.
 

 

 

The Readers Digest cited breakthroughs of the month for September 2008. One of the the items listed is as follows:

Melanoma Hope (reproduced)

Cloned immune cells show promise in fighting the deadliest form of skin cancer. Researchers removed white blood cells that naturally fight cancer from a patient with late-stage melanoma. They cloned them in the lab, then returned more of the cells to the patient by IV. Two months later, the patient was tumor-free. Researchers think this therapy could be used for a quarter of all late-stage melanoma cases. Unfortunately, it will be available in 8-10 years - not sooner.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

The Two-Minute Cancer Test

Glamour Magazine - May 2008

Last year, Glamour published a feature about skin cancer—how to avoid it, how to spot it. After it hit newsstands, something remarkable happened—letters started to pour in from readers. What they read was amazing! So far, that article has saved 23 readers' lives.

To read the article in its entirety, click here.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Targeted Assault on Melanoma
Readers Digest, March 2008

The skin cancer melanoma is treatable when caught early but often deadly if it has spread. New hopes:

*Doctors at the National Cancer Institute remove cancer-fighting cells from late-stage patients, grow more and then give them back. So far, this immunotherapy has shown it can shrink tumors in about 75% of the patients.

*The myeloma drug Velcade seems to put skin cancer cells in overdrive so they self-destruct, according to the doctors at the University of Michigan. Even better, it kills only the cancerous cells.

Next up (in 5+ years), seeing how actual patients react to Velcade, as this research was done only in a petri dish.

 


DermAlert Software
DermAlert® software is designed to enable individuals to carefully compare images of their body (moles, etc.) obtained at different times (for example, 6 months or a year apart) to look for changes that have occurred. For more information, check out their web site at DermAlert® Product Web Site To view this presentation, click on the link. When you get to the website, click on "Next" on the left-hand side of the page to advance to the next page of the presentation.





More Links:
image
Contact us
image
View our F.A.Q.section
image
Site Map
image
       
image